Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  18,029 results for ""United States. Food and Drug Administration""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Phosphodiesterase type 5 inhibitors related hearing impairment: a real world study based on the FDA adverse event reporting system.

  • Authors : Zhang X; Department of Pharmacy, Suining Central Hospital, No.127, West Desheng Road, Chuanshan District, Suining, 629000, Sichuan, People's Republic of China.; Xia L

Subjects: United States Food and Drug Administration* ; Hearing Loss*/Hearing Loss*/Hearing Loss*/chemically induced ; Hearing Loss*/Hearing Loss*/Hearing Loss*/epidemiology

  • Source: Scientific reports [Sci Rep] 2024 Apr 28; Vol. 14 (1), pp. 9743. Date of Electronic Publication: 2024 Apr 28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

An empirical analysis of overall survival in drug approvals by the US FDA (2006-2023).

  • Authors : Elbaz J; Hofstra University, Hempstead, New York, USA.; Haslam A

Subjects: Drug Approval*/Drug Approval*/Drug Approval*/statistics & numerical data ; United States Food and Drug Administration* ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/therapeutic use

  • Source: Cancer medicine [Cancer Med] 2024 Apr; Vol. 13 (8), pp. e7190.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication

Record details

×
Periodical

'Damning' FDA inspection report undermines Alzheimer's drug.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Scientific Misconduct* ; Spiro Compounds*/Spiro Compounds*/Spiro Compounds*/therapeutic use

  • Source: Science (New York, N.Y.) [Science] 2024 Mar 15; Vol. 383 (6688), pp. 1165-1166. Date of Electronic Publication: 2024 Mar 14.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID:

Record details

×
Periodical

Utah flouts FDA with new placental stem cell law.

Subjects: Placenta*/Placenta*/Placenta*/cytology ; Stem Cells*/Stem Cells*/Stem Cells*/cytology ; Stem Cell Transplantation*/Stem Cell Transplantation*/Stem Cell Transplantation*/legislation & jurisprudence

  • Source: Science (New York, N.Y.) [Science] 2024 Apr 05; Vol. 384 (6691), pp. 14-15. Date of Electronic Publication: 2024 Apr 04.Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID:

Record details

×
Academic Journal

Postmarket safety communications on drugs approved in Japan: A 25-year analysis.

  • Authors : Tanaka Y; Clinical and Translational Research Center, Niigata University Medical and Dental Hospital, Niigata, Japan.; Tanaka M

Subjects: Drug Approval* ; Product Surveillance, Postmarketing*/Product Surveillance, Postmarketing*/Product Surveillance, Postmarketing*/statistics & numerical data ; Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/Drug-Related Side Effects and Adverse Reactions*/epidemiology

  • Source: Clinical and translational science [Clin Transl Sci] 2024 Apr; Vol. 17 (4), pp. e13803.Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication

Record details

×
Academic Journal

Analysis of post-market adverse events of istradefylline: a real-world study base on FAERS database.

  • Authors : Jiang Y; Mental Health Center of Jiangnan University, Wuxi Central Rehabilitation Hospital, Wuxi, 214151, Jiangsu, China.; Lu R

Subjects: Compulsive Behavior* ; Purines*/Purines*/Purines*/adverse effects; United States

  • Source: Scientific reports [Sci Rep] 2024 Apr 01; Vol. 14 (1), pp. 7659. Date of Electronic Publication: 2024 Apr 01.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A Review of FDA-Approved Anti-HIV-1 Drugs, Anti-Gag Compounds, and Potential Strategies for HIV-1 Eradication.

  • Authors : Sever B; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, Eskisehir 26470, Türkiye.; Medicinal and Biological Chemistry Science Farm Joint Research Laboratory, Faculty of Life Sciences, Kumamoto University, Kumamoto 862-0973, Japan.

Subjects: HIV-1* ; Acquired Immunodeficiency Syndrome*; United States

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Mar 25; Vol. 25 (7). Date of Electronic Publication: 2024 Mar 25.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

A review of the clinical efficacy of FDA-approved antibody‒drug conjugates in human cancers.

  • Authors : Liu K; Laboratory of Urology, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.; The First Clinical College, Guangdong Medical University, Zhanjiang, 524023, China.

Subjects: Immunoconjugates*/Immunoconjugates*/Immunoconjugates*/therapeutic use ; Neoplasms*/Neoplasms*/Neoplasms*/drug therapy ; Neoplasms*/Neoplasms*/Neoplasms*/pathology

  • Source: Molecular cancer [Mol Cancer] 2024 Mar 23; Vol. 23 (1), pp. 62. Date of Electronic Publication: 2024 Mar 23.Publisher: BioMed Central Country of Publication: England NLM ID: 101147698 Publication Model: Electronic Cited Medium: Internet ISSN: 1476-4598

Record details

×
Academic Journal

Amidst spreading infectious diseases and climate change, US FDA should renew its focus on neglected tropical diseases.

  • Authors : Berger M; US Federal Government, Rockville, Maryland, United States of America.

Subjects: Communicable Diseases*/Communicable Diseases*/Communicable Diseases*/epidemiology ; Tropical Medicine*; United States/United States/United States/epidemiology

  • Source: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Mar 21; Vol. 18 (3), pp. e0012005. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488

Record details

×
Academic Journal

Exposure Among Middle and High School Students to Warning Labels on E-Cigarette Packages Before and After an FDA Requirement, 2018-2019.

  • Authors : Snyder K; Office of Science, Center for Tobacco Products, US Food and Drug Administration, Silver Spring, Maryland.; Office of Science, Center for Tobacco Products, Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993 ().

Subjects: Electronic Nicotine Delivery Systems* ; Product Labeling* ; Tobacco Products*

  • Source: Preventing chronic disease [Prev Chronic Dis] 2024 Mar 14; Vol. 21, pp. E16. Date of Electronic Publication: 2024 Mar 14.Publisher: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion Country of

Record details

×
  • 1-10 of  18,029 results for ""United States. Food and Drug Administration""